ASO Visual Abstract: Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.

IF 3.4 2区医学 Q2 ONCOLOGY

Annals of Surgical Oncology Pub Date : 2025-04-02 DOI:10.1245/s10434-025-17248-2

Lauren M Perry, Varadan Sevilimedu, Natalia Polidorio, Nour Abuhadra, Monica Morrow, George Plitas, Stephanie Downs-Canner

引用次数: 0

查看原文本刊更多论文

早期三阴性乳腺癌新辅助化疗-免疫治疗病理完全缓解的预测因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Surgical Oncology 医学-外科

CiteScore

5.90

自引率

10.80%

发文量

1698

审稿时长

2.8 months

期刊介绍： The Annals of Surgical Oncology is the official journal of The Society of Surgical Oncology and is published for the Society by Springer. The Annals publishes original and educational manuscripts about oncology for surgeons from all specialities in academic and community settings.